Healthpeak properties, inc. (HCP)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

60,061

1,073,474

422,634

639,926

-546,418

936,591

985,006

846,842

554,494

344,395

146,151

470,983

614,115

Discontinued operations

-

-

-

-

-

-

5,862

12,808

11,340

6,513

4,389

9,227

24,171

Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization of real estate, in-place lease and other intangibles

659,989

549,499

534,726

568,108

504,905

455,016

423,312

353,704

346,055

306,934

315,736

312,009

257,008

Depreciation and Amortization, Discontinued Operations

-

-

-

4,890

5,880

4,979

-

-

-

-

-

-

-

Amortization of market lease intangibles, net

-

-

-

-

-

-949

-6,646

-2,232

-4,510

-6,378

-14,780

-8,440

-6,056

Amortization of deferred compensation

18,162

16,563

14,258

22,884

26,127

21,885

39,980

23,277

20,034

14,924

14,388

13,765

11,408

Amortization of deferred financing costs

10,863

12,612

14,569

20,014

20,222

19,260

18,541

16,501

25,769

9,856

8,328

9,869

17,781

Straight-line rents

22,479

23,138

23,933

18,003

28,859

41,032

39,587

47,311

59,173

47,243

46,688

39,463

49,725

Loan and direct financing lease non-cash interest, net: continuing operations

-

-

-

-

-5,648

1,063

-

-

-

-

-

-

-

Loan and direct financing lease non-cash interest, net: discontinued operations

-

-

-

-

-90,065

-79,349

-

-

-

-

-

-

-

Loan and direct financing lease non-cash interest

-

-

-

-

-

-

86,314

-95,444

-93,003

-69,645

-39,172

-27,019

-8,739

Deferred rental revenues

-

-

-

-

-

1,884

2,843

1,655

2,319

3,984

-12,804

-13,931

-9,027

Income (Loss) from Equity Method Investments

-8,625

-2,594

10,901

11,360

57,313

49,570

64,433

54,455

46,750

4,770

3,511

3,326

5,645

Distributions of earnings from unconsolidated joint ventures

20,114

22,467

44,142

26,492

15,111

5,045

3,989

3,384

3,273

5,373

7,273

6,745

5,264

Non-cash lease and management fee termination loss (income), net

0

0

-54,641

0

1,103

38,001

-

-

-

-

-

-

-

Deferred income tax expense (benefit)

-18,253

-18,525

-5,523

47,195

0

-

-

-

-

-

-

-

-

Allowance for loan losses

-

-

-

-

-

-

-

-

-

-

-

-

-386

Asset Impairment Charges

225,937

55,260

166,384

0

1,449,748

-

-

-

-

-

-

-

-

Gain (Loss) on Extinguishment of Debt

-58,364

-44,162

-54,227

-46,020

0

-

-

-

-

-

-

2,396

-

Gain upon settlement of loans receivable

-

-

-

-

-

-

-

-

22,812

-

-

-

-

Loss (gain) on sales of real estate, net

22,900

925,985

356,641

164,698

6,377

31,298

69,866

31,454

3,107

19,925

37,321

229,189

414,469

Gain (Loss) On Consolidation

168,023

9,154

0

0

-

-

-

-

-

-

-

-

-

Casualty-related loss (recoveries), net

3,706

0

-12,053

0

0

-

-

-

-

-

-

-

-

Foreign exchange and other losses (gains), net

-

-

-

-

-

2,270

10,817

-43

-5,396

14,597

8,876

-7,230

2,233

Loss (gain) on sale of marketable securities

0

0

50,895

0

0

-

-

-

-

-

-

-

-

Other non-cash items

2,569

-2,569

2,735

2,369

11,286

-

-

-

-

-

-

-

-

Decrease (increase) in accounts receivable and other assets, net

49,771

-5,686

24,782

6,992

29,022

-

-

-

-

-

-

-

-

Gain upon consolidation of joint venture

-

-

-

-

-

-

-

-

7,769

-

-

-

-

Foreign currency and derivative (gains) losses, net

-

-

-

-

-

-

-

-

1,226

-1,302

-

-

-

Derivative (gains) losses, net

-

-

-

-

-

-

-

-

-

-

-69

-4,577

-

Impairment, net

-

-

-

-

-

35,913

1,372

7,878

15,400

59,793

75,514

27,851

-

Accounts receivable, net

-

-

-

-

-

8,845

-6,656

7,469

-2,590

-9,222

-4,408

-10,681

13,115

Other assets, net

-

-

-

-

-

6,287

58,290

3,814

-27,582

6,341

6,881

1,315

11,989

Accrued liability for litigation provision

-

-

-

-

-

-

-

-

-

-

101,973

-

-

Increase (decrease) in accounts payable, accrued liabilities and deferred revenue

71,659

40,625

4,817

42,024

-23,757

28,354

3,065

14,267

-47,103

-4,931

-18,170

-7,023

26,634

Net cash provided by (used in) operating activities

846,073

848,709

847,041

1,214,131

1,222,145

1,248,621

1,148,987

1,034,870

724,161

580,498

515,634

568,697

453,051

Cash flows from investing activities:
Acquisition of RIDEA III, net

-

-

-

-

768,413

-

-

1,701,410

-

-

-

-

-

Acquisition of the CCRC unconsolidated joint venture interest, net

-

-

-

-

-

370,186

-

-

95,000

6,565

7,975

3,579

3,641

Acquisitions of real estate

1,604,285

426,080

560,753

467,162

613,252

503,470

64,678

186,478

113,324

212,005

-

-

-

Development, redevelopment, and other major improvements of real estate

626,904

503,643

373,479

421,322

281,017

178,513

130,317

133,596

85,061

92,842

-

-

-

Other acquisitions and development of real estate

-

-

-

-

-

-

-

-

-

-

96,528

155,531

425,464

Leasing costs, tenant improvements, and recurring capital expenditures

108,844

106,193

115,260

91,442

84,282

71,734

64,557

61,440

52,903

97,930

40,702

59,991

49,669

Proceeds from sales of real estate, net

230,455

2,044,477

1,314,325

647,754

73,149

104,557

95,816

150,943

19,183

32,284

72,272

639,585

-

Contributions to unconsolidated joint ventures

14,956

12,203

46,334

10,186

69,936

2,935

-

-

135,550

-

-

-

-

Distributions in excess of earnings from unconsolidated joint ventures

27,072

26,472

37,023

28,366

30,989

2,657

14,102

2,915

2,408

4,365

6,869

8,400

478,293

Proceeds from insurance recovery

9,359

0

0

-

-

-

-

-

-

-

-

-

-

Proceeds from Sale of Buildings

0

335,709

462,242

0

0

-

-

-

-

-

-

-

-

Proceeds from sales of marketable securities

-

-

-

-

-

-

28,403

-

-

179,215

157,122

10,700

53,817

Proceeds from the U.K. JV transaction, net

89,868

393,997

0

0

-

-

-

-

-

-

-

2,855

-

Proceeds from Divestiture of Interest in Subsidiaries and Affiliates

354,774

0

0

-

-

-

-

-

-

-

-

-

-

Proceeds from sales/principal repayments on debt investments and direct financing leases

274,150

148,024

558,769

231,990

628,049

119,511

263,445

45,046

303,941

63,953

10,952

16,790

104,009

Investments in loans receivable, direct financing leases and other

79,467

71,281

30,276

273,693

575,652

600,019

322,775

218,978

369,939

298,085

165,494

3,162

923,534

Purchase of securities for debt defeasance

-

-

-

73,278

0

-

16,706

214,859

22,449

-

-

30,089

26,647

Proceeds from sales of real estate

-

-

-

-

-

-

-

-

-

-

-

-

887,218

Cash used in the HCR ManorCare Acquisition, net of cash acquired

-

-

-

-

-

-

-

-

4,026,556

-

-

-

2,982,689

Decrease (increase) in restricted cash

-

-

-

-

-

11,747

-619

-3,705

5,234

3,319

-2,078

-1,349

-192

Net cash provided by (used in) investing activities

-1,448,778

1,829,279

1,246,257

-428,973

-1,660,365

-1,511,879

-196,648

-2,314,152

-4,580,484

-430,929

-61,406

427,327

-2,888,115

Cash flows from financing activities:
Borrowings under bank line of credit

7,607,788

1,823,000

1,244,189

1,108,417

98,743

845,190

-

-454,000

454,000

-

-150,000

801,700

-327,200

Repayments under bank line of credit and commercial paper

7,597,047

2,755,668

1,150,596

540,000

511,521

-

-

-

-

-

-

-

-

Proceeds related to QCP Spin-Off, net

-

-

-

1,685,172

0

-

-

-

-

-

-

-

-

Proceeds from Bank Debt

2,047,069

223,587

5,395

0

2,269,031

-

-

-

-

-

-

-

-

Repayments and repurchase of debt, excluding bank line of credit and commercial paper

1,654,142

1,604,026

1,468,446

2,316,774

457,845

-

-

-

-

-

-

-

-

Borrowings under term loan

250,000

0

0

-

-

-

-

-

-

-

-

-

-

Repayments of term loan

-

-

-

-

-

-

-

214,789

-

-

-

200,000

2,750,000

Repayments of term loan

-

-

-

-

-

-

-

-

-

200,000

320,000

1,030,000

1,904,593

Issuance of senior unsecured notes

-

-

-

-

-

1,150,000

800,000

1,550,000

2,400,000

-

-

-

1,100,000

Repayments of senior unsecured notes

-

-

-

-

-

487,000

550,000

250,000

292,265

206,422

7,735

300,000

20,000

Issuance of mortgage and other debt

-

-

-

-

-

35,445

6,798

-

-

-

1,942

579,557

143,421

Repayments of mortgage and other debt

-

-

-

-

-

447,784

302,119

155,565

169,783

636,096

234,080

225,316

97,882

Payments for debt extinguishment and deferred financing costs

80,616

41,552

51,415

54,856

19,995

-

-

-

-

-

-

-

-

Settlement of cash flow hedges, net

-

-

-

-

-

-

-

-

-

-

-

9,658

-

Deferred financing costs

-

-

-

-

-

16,550

7,300

27,565

43,716

11,850

860

12,657

27,044

Preferred stock redemption

-

-

-

-

-

-

-

295,500

-

-

-

-

-

Issuance of common stock and exercise of options

795,586

217,656

28,121

67,650

206,471

96,592

114,082

1,792,786

1,327,813

2,426,900

852,912

1,060,538

618,854

Repurchase of common stock

5,043

3,432

4,785

8,685

8,738

12,703

-

-

-

-

-

-

-

Dividends paid on common stock

720,123

696,913

694,955

979,542

1,046,638

1,001,559

956,685

865,306

787,689

590,735

517,072

457,643

393,566

Issuance of noncontrolling interests

33,318

299,666

1,615

11,834

110,775

4,674

12,472

1,584

14,028

8,395

-

-

-

Purchase of noncontrolling interests

-

-

-

-

-

5,897

-

2,143

34,104

-

9,097

-

-

Distributions to and purchase of noncontrolling interests

29,519

82,854

57,584

27,481

26,196

15,611

17,664

15,631

15,156

15,319

15,541

37,852

23,462

Net cash provided by (used in) financing activities

647,271

-2,620,536

-2,148,461

-1,054,265

614,087

144,797

-900,416

1,493,449

2,853,128

774,873

-399,531

-1,034,731

2,472,928

Effect of foreign exchanges on cash, cash equivalents and restricted cash

245

191

376

-1,019

-1,537

1,715

960

-

-

-

-

-

-

Net increase (decrease) in cash, cash equivalents and restricted cash

44,811

57,643

-54,787

-270,126

174,330

-116,746

52,883

214,167

-1,003,195

924,442

54,697

-38,707

37,864